CIK 0001649904 · Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462159271
- Phone
- 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-14 | Meeker David P President and CEO | Option exercise 10b5-1 | +50,000 | $6.05 | $303K | 289,258 |
| 2026-09-14 | Meeker David P President and CEO | Sale 10b5-1 | −6,439 | $101.75 | $655K | 282,819 |
| 2026-09-14 | Meeker David P President and CEO | Sale 10b5-1 | −30,746 | $102.35 | $3.1M | 252,073 |
| 2026-09-14 | Meeker David P President and CEO | Sale 10b5-1 | −8,698 | $103.43 | $900K | 243,375 |
| 2026-09-14 | Meeker David P President and CEO | Sale 10b5-1 | −1,817 | $104.55 | $190K | 241,558 |
| 2026-09-14 | Meeker David P President and CEO | Sale 10b5-1 | −2,300 | $105.19 | $242K | 239,258 |
| 2026-09-14 | Meeker David P President and CEO | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −50,000 | 15,431 | ||
| 2026-02-11 | Meeker David P President and CEO | Grant or award · Restricted Stock Units | +71,900 | 71,900 | ||
| 2026-02-11 | Meeker David P President and CEO | Grant or award · Stock Options (Right to Buy) | +107,850 | 107,850 | ||
| 2026-02-01 | Meeker David P President and CEO | Option exercise | +68,713 | 270,538 | ||
| 2026-02-01 | Meeker David P President and CEO | Shares withheld for taxes | −31,522 | $108.99 | $3.4M | 239,016 |
| 2026-02-01 | Meeker David P President and CEO | Option exercise · Restricted Stock Units | −14,125 | 14,125 | ||
| 2026-02-01 | Meeker David P President and CEO | Option exercise · Restricted Stock Units | −21,250 | 42,500 | ||
| 2026-02-01 | Meeker David P President and CEO | Option exercise · Restricted Stock Units | −33,338 | 100,012 | ||
| 2025-06-03 | Meeker David P President and CEO | Option exercise 10b5-1 | +43,620 | $4.59 | $200K | 245,445 |
| 2025-06-03 | Meeker David P President and CEO | Sale 10b5-1 | −43,346 | $65.04 | $2.8M | 202,099 |
| 2025-06-03 | Meeker David P President and CEO | Sale 10b5-1 | −274 | $65.60 | $18K | 201,825 |
| 2025-06-03 | Meeker David P President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −43,620 | 0 | ||
| 2025-02-19 | Meeker David P President and CEO | Sale 10b5-1 | −9,896 | $57.22 | $566K | 201,281 |
| 2025-02-16 | Meeker David P President and CEO | Option exercise 10b5-1 | +21,250 | 211,177 |
Page 1 of 2 · 23 trades